Drug Target Review2024-05-23T12:00:22
This is the first study to demonstrate that a specific set of HERVs expressed in the human brain contribute to disorders like schizophrenia.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-05-14T14:30:00
Sponsored by Abzena
2025-08-05T13:42:00
Sponsored by ICON plc., Drug Target Review
2023-03-03T14:06:14
Sponsored by Bio-Techne
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud